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The purpose of this study was to assess the role of bronchoalveolar lavage (BAL) in
differentiating usual interstitial peumonia (UIP) from non-specific interstitial pneumonia
(NSIP) and in predicting the prognosis in fibrotic idiopathic interstitial pneumonia (IIP).
A retrospective review of 122 patients (age 5878 years, 70 male) with UIP (n ¼ 87) and
NSIP (n ¼ 35) was carried out. Prior to surgical lung biopsy, all of them underwent BAL and
high-resolution-computed tomography (HRCT) of the chest. Neutrophil count in BAL fluid
was higher in UIP (7.0%) than NSIP (3.0%) (P ¼ 0:027). In contrast, BAL lymphocyte count
was significantly higher in NSIP (29.0%) than UIP (5.5%) (Po0:0001). In 62 patients whose
HRCT findings were atypical for UIP, BAL lymphocytosis was more frequently observed in
NSIP (20/33) than UIP (4/29) (Po0:001) and the absence of BAL lymphocytosis suggested a
diagnosis of UIP rather than NSIP (odds ratio 12.7, Po0:001). Pathologic diagnosis of NSIP
was the only independent factor predicting a longer survival of our patients (median
follow-up 21 months) (hazard ratio (HR) 0.035, P ¼ 0:005). When NSIP was not included in
the survival analysis, higher BAL lymphocyte count was the only independent predictor of aElsevier Ltd. All rights reserved.
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Y. Ju Ryu et al.656longer survival (HR 0.909, P ¼ 0:029). BAL is an useful non-invasive tool in fibrotic IIP, not
only for excluding a variety of specific non-IIP diseases but also for narrowing the
differential diagnosis and predicting the prognosis in the absence of the histopathologic
diagnosis.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Idiopathic interstitial pneumonias (IIP) are a heterogeneous
group of diffuse parenchymal lung diseases of unknown
etiology.1 Because of the differences in the clinical
manifestations, the radiographic features and the prognosis,
IIP are classified into seven histopathologic entities that
include idiopathic pulmonary fibrosis (IPF) and non-specific
interstitial pneumonia (NSIP).1 Surgical lung biopsy, how-
ever, is not feasible in all the patients with IIP since it
requires general anesthesia and adequate interpretation by
an experienced lung pathologist. In addition, lobar histolo-
gic variability and inter-observer variation in the histo-
pathologic interpretation of IIP make it less reliable to use
the histology alone as the diagnostic ‘‘gold standard’’.2–5
A recent report by Nicholson et al.6 showed that more than
half of the inter-observer variation in the histopathologic
interpretation was related to the diagnosis of NSIP and its
distinction from usual interstitial pneumonia (UIP). Separat-
ing NSIP from UIP is important because NSIP has a better
prognosis than UIP.7–12
Bronchoalveolar lavage (BAL) is a non-invasive diagnostic
procedure in interstitial lung diseases (ILD), not only for the
diagnosis of certain non-IIP diseases such as hypersensitivity
pneumonitis, sarcoidosis or pulmonary alveolar proteinosis
but also for the exclusion of infection or malignancy.13–15 In
the patients suspected to have UIP or NSIP, analysis of the
differential white blood cell counts in BAL fluid can be also
helpful. In the past, BAL lymphocytosis was known to be a
good prognostic factor while BAL neutrophilia or eosinophi-
lia denoted a poor clinical outcome in the patients with
UIP.16–21 After the first description of NSIP in 1994, BAL
lymphocytosis is more likely suggestive of NSIP rather than
UIP.20 A few recent studies have also shown that BAL could
provide substantial diagnostic information on UIP and
NSIP.8,9,22 Veeraraghavan et al.,23 however, reported that
BAL had neither diagnostic role nor prognostic value in 54
patients with either IPF or idiopathic NSIP. Therefore the
role of BAL in fibrotic IIP is still controversial.
This retrospective study was undertaken to identify the
role of BAL in the separation of NSIP from UIP in the large
number of patients with fibrotic IIP. We also evaluated
whether the BAL findings can predict the prognosis in the
absence of the histopathologic diagnosis.
Methods
Between May 1995 and April 2004, a total of 122 patients
with UIP (n ¼ 87) or idiopathic NSIP (n ¼ 35) were patholo-
gically confirmed by surgical lung biopsy. During this period,
open thoracotomy or video-assisted thoracoscopic surgery
was performed for a diagnostic purpose in 313 patients withILD at Samsung Medical Center, which is a tertiary referral
hospital in Korea. Following the investigation for collagen
vascular diseases including the examination by a rheumatol-
ogist and serologic tests, a standardized evaluation for
environmental or occupational exposure, and a search for
the ingestion of any drugs known to cause ILD, 193 patients
were confirmed to have IIP. Among them, 148 patients
underwent BAL procedures prior to surgical lung biopsy.
Lung biopsy specimen was obtained from at least two
different lobes. The pathology slides of 148 patients were
independently reviewed by two experienced lung patholo-
gists (J.H. and T.C.). Except for age, sex and the site of
biopsy, clinical information was not provided to the
pathologists. The kappa coefficient used to measure the
agreement between the two pathologists was 0.67. Twenty-
six patients were excluded from the study because the
pathologic diagnosis did not concur. A total of 122 patients
(87 patients with UIP and 35 patients with idiopathic NSIP)
were finally included in the study. The patients with NSIP
were further divided into those with cellular NSIP (n ¼ 6)
and fibrotic NSIP (n ¼ 29).7,12
Following a review of the medical records, the data on
the age at the time of diagnosis, the gender, the smoking
history, the respiratory symptoms and their duration,
arterial blood gas analysis when breathing room air, the
medical treatment, and the final clinical outcome were
obtained. The forced vital capacity (FVC) (n ¼ 111), total
lung capacity (TLC) (n ¼ 82) and diffusing capacity of the
lung (DLco) (n ¼ 84) were examined with pulmonary func-
tion units (SensorMedics, Yorba Linda, CA, USA). Pulmonary
function tests could not be performed in all the
patients because of intractable coughing, dyspnea or poor
cooperation.
High-resolution-computed tomography (HRCT) of the
chest was done prior to surgical lung biopsy in all
the patients. Two chest radiologists (TS K. and KS L.)
reached decisions on CT findings by consensus. The
typical HRCT findings of IPF are areas of irregular linear
opacity, traction bronchiectasis and honeycombing that
predominantly involve the basal and subpleural lung with
minimal ground-glass attenuation.24,25 If the HRCT findings
were typical for IPF, the radiographic diagnosis was ‘‘con-
fident IPF’’.
BAL was performed as previously described.26 A flexible
bronchoscope (EVIS BF 1T240, Olympus, Japan) was wedged
into a segmental or subsegmental bronchus of the most
involved segment, or of the right middle lobe or the lingular
segment. Warm saline was then infused in five 30–50ml
aliquots up to total volume of 150–200ml. After each
instillation of saline, BAL fluid was retrieved by gentle
suction and the samples were pooled. The recovery
percentage of BAL fluid ranged between 45% and 68%, with
an average rate of 56%. Cytocentrifuge preparations were
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UK), and the differential cell count was performed with
using Wright–Giemsa staining. A total of 300–500 cells from
a cytospin slide were counted. The results of differential
cell counts in BAL fluid were classified as BAL lymphocytosis
(lymphocytes 420% of total white blood cells) or BAL
neutrophilia (neutrophils 45% of total white blood
cells).20,21 BAL eosinophilia was absent in our patients.
Medical treatment consisted of corticosteroids (1mg/kg/
day of prednisolone for 1–2 months with subsequent
tapering) with or without either azathioprine (2–3mg/kg/
day to a maximum dose of 150mg/day) or cyclophosphamide
(2mg/kg/day to a maximum dose of 150mg/day).20 Some
patients were managed with symptomatic supportive care
(n ¼ 19) or subcutaneous injection of interferon-gamma
(n ¼ 24). Serial changes in the respiratory symptoms, chest
radiography and pulmonary function tests were evaluated at
3–6 month intervals. Survival and the causes of death were
identified from the medical records, by interviews with the
patients’ families/doctors or by accessing the national
death registry data.
For statistical analysis, SPSS version 11.5 was used.
A P-value of less than 0.05 was considered significant. Group
comparisons for categorical variables were made with using
Pearson w2 test or Fisher’s exact test. To compare between
the three groups for the continuous variables, ANOVA test for
the normally distributed data or Kruskal–Wallis test for the
data that was not normally distributed was performed. For
comparison between two groups, student t-test for the
normally distributed data or Mann–Whiney U-test for the
data that was not normally distributed was used. For survival
analysis, Kaplan–Meier analysis with a log-rank test was
used. Time zero was determined as the date of surgical lung
biopsy. Cox proportional hazard multivariate analysis was
performed to identify the independent factors that were
closely related to death.Table 1 Baseline clinical profiles of the patients with IPF and
Variables IPF (n ¼ 87) Idiop
Cellu
(n ¼
Age (years) 5977 5174
Gender (M:F) 62:25 0:06
Smoking history
Never smoker (number) 32 6
Ex-smoker (number) 28 0
Current smoker (number) 27 0
Duration of symptoms (months) 12 (0–120) 2 (1–
Pulmonary function at diagnosis
PaO2 at room air (mmHg) 82.4713.1 74.17
FVC (% predicted) 75.0716.5 70.27
TLC (% predicted) 78.7718.3 73.07
DLCO (% predicted) 66.4718.2 74.57
Immunosuppressive therapy (%) 70 100
Values are expressed as means7SD, medians (ranges) or frequencies
When compared between IPF and idiopathic NSIP. NS: Not significResults
Baseline characteristics of the patients
Among 122 patients, there were 70 male and 52 female
patients with a mean age of 5878 years. Compared to UIP,
the patients with NSIP had a younger age, a female
predilection, more non-smokers and a shorter duration of
respiratory symptoms (Po0:05) (Table 1). Initial FVC, DLco
and arterial oxygen tension when breathing room air were
not different between the two groups. The proportion of
patients who received corticosteroids and/or cytotoxic
agents was not different either.Diagnostic value of BAL in separating NSIP from IPF
Neutrophil count in BAL fluid was significantly higher in UIP
(7.0%) than NSIP (3.0%) (P ¼ 0:027) (Table 2). The patients
showing BAL neutrophilia was also much more in UIP (49/87)
than NSIP (12/35) (P ¼ 0:028). In contrast, lymphocyte
count in BAL fluid was significantly higher in NSIP (29.0%)
than UIP (5.5%) (Po0:0001). BAL lymphocytosis was more
frequently found in NSIP (20/35) than UIP (14/87)
(Po0:0001). When compared between UIP and fibrotic NSIP,
these differences were also observed. After adjusted for
smoking, BAL neutrophilia (P ¼ 0:040) and BAL lymphocy-
tosis (P ¼ 0:026) were still more frequently present in UIP
and fibrotic NSIP, respectively.
Among the 60 patients whose HRCT diagnosis was
confident UIP, 58 patients (97%) were confirmed to have
UIP on surgical lung biopsy. In particular, all of 35 patients
with BAL neutrophilia showed UIP pathologically. In the
remaining 62 patients whose HRCT features were atypical
for UIP, BAL lymphocytosis was more frequently observed in
NSIP (20/33) than UIP (4/29) (Po0:001) while the absence ofidiopathic NSIP.
athic NSIP P-value
lar Fibrotic Both
6) (n ¼ 29) (n ¼ 35)
55712 54711 o0.05
8:21 8:27 o0.05
23 29
5 5 o0.05
1 1
4) 5 (1–72) 4 (1–72) o0.05
11.9 82.2716.0 81.2715.6 NS
8.8 67.4717.2 67.9716.1 NS
19.5 73.0717.6 73.0717.5 NS
16.3 62.5715.1 64.2715.5 NS
93 94 NS
(%).
ant.
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Table 2 Bronchoalveolar lavage (BAL) findings and their relationship with HRCT diagnosis in IPF and idiopathic NSIP.
Variables IPF (n ¼ 87) Idiopathic NSIP P-value
Cellular Fibrotic Both
(n ¼ 6) (n ¼ 29) (n ¼ 35)
BAL neutrophils
Counts (%) (ranges) 7.0(0–85) 3.5(1–25) 3.0(0–38) 3.0(0–38) o0.05
Neutrophilia (+) (n) 49 2 10 12 o0.05
BAL lymphocytes
Counts (%) (ranges) 5.5(0–68) 40.5(29–76) 19.0(4–71) 29.0(4–76) o0.05
Lymphocytosis (+) (n) 14 6 14 20 o0.05
HRCT diagnosis
Confident IPF (n) 58 0 2 2 o0.05
BAL neutrophilia (+) 35/58 0 0 0 NS
BAL lymphocytosis (+) 10/58 0 1/2 1/2 NS
Not confident IPF (n) 29 6 27 33 o0.05
BAL neutrophilia (+) 14/29 2/6 10/27 12/33 NS
BAL lymphocytosis (+) 4/29 6/6 14/27 20/33 o0.05
Values are expressed as medians (ranges) or as the number of patients.
When compared between IPF and idiopathic NSIP.
Y. Ju Ryu et al.658BAL lymphocytosis suggested a diagnosis of UIP (odds ratio
(OR) 12.7, Po0:001). The presence of BAL neutrophilia,
however, could not predict a diagnosis of IPF (P ¼ 0:343).Figure 1 The Kaplan–Meier survival curve of 122 patients with
IPF (n ¼ 87) and idiopathic NSIP (n ¼ 35).The value of BAL for the prediction of survival in
patients with IPF and NSIP
The patients were followed for a median of 21 months
(range 0–104 months). The median survival time was 71
months (36–106 months) for the patients with UIP and 95
months (90–100 months) for the patients with idiopathic
NSIP (P ¼ 0:0001) (Fig. 1). A total of 36 patients died during
the follow-up. Progression of interstitial pneumonia was the
cause of death in 29 patients (acute exacerbation in 20 and
slow progression in 9). Among the 29 patients, 28 patients
had UIP. The seven patients who died of other causes, such
as lung cancer (n ¼ 3), infectious pneumonia (n ¼ 3) and
post-operative acute respiratory distress syndrome (n ¼ 1),
were excluded from the survival analysis. In multivariate
survival analysis with a Cox proportional hazards model, the
pathologic diagnosis of NSIP was the only independent
predictive factor for a longer survival (hazard ratio (HR)
0.035, P ¼ 0:005). When the pathologic diagnosis was not
included in the analysis, higher lymphocyte count in BAL
fluid was the other only predictive factor for a longer
survival (HR 0.909, P ¼ 0:029). As shown in Fig. 2, survival
was not different between UIP patients with BAL lympho-
cytosis and NSIP patients without BAL lymphocytosis
(P ¼ 0:743). The patients with UIP showing BAL lymphocy-
tosis had a tendency of better survival than those without
BAL lymphocytosis, but it did not reach a statistical
significance (P ¼ 0:073). Kaplan–Meier survival analysis
showed that BAL lymphocytosis was associated with better
survival (Fig. 3). The survival was not affected by age(P ¼ 0:779), sex (P ¼ 0:079) and the treatment with corti-
costeroids and/or cytotoxic agents (P ¼ 0:167).Discussion
Our study showed that analysis of the differential white
blood cell count in BAL fluid was useful not only for
separating NSIP from UIP, but also for predicting the
prognosis in patients with fibrotic IIP. In particular, the
presence or absence of BAL lymphocytosis was important.
Unless pathologic diagnosis was confirmed, it can be an
independent predictor of good prognosis in fibrotic IIP.
Our observations are meaningful from a clinical aspect
because BAL could give valuable information on the
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Figure 2 Survival of the patients with UIP and NSIP according
to the presence and absence of BAL lymphocytosis. *P-
valueo0.05 when compared with D group.
Figure 3 Survival of patients with fibrotic idiopathic inter-
stitial pneumonia in relation to BAL lymphocytosis.
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are suspected of having UIP or idiopathic NSIP. Old age,
decreased lung function and coexisting illnesses of the
patients with fibrotic IIP can make surgical lung biopsy
difficult to perform. When the risk of undergoing surgical
lung biopsy exceeds the benefit, the patients with IIP should
be evaluated by non-invasive procedures. HRCT is a crucial
tool for the differential diagnosis and for predicting the
reversibility of lung lesion in IIP.1,3,24,25 In our study, 97% of
the patients with HRCT diagnosis of confident UIP were
confirmed to have UIP on surgical lung biopsy. When both
HRCT diagnosis of confident UIP and BAL neutrophilia were
present, all of them were pathologically diagnosed as UIP. In
the 62 patients whose HRCT diagnosis was not confident UIP,the absence of BAL lymphocytosis suggested a diagnosis of
UIP. When HRCT findings are atypical for UIP, the current
recommendation by ATS/ERS is to get a histopathologic
diagnosis with or without performing BAL prior to surgical
lung biopsy.20 Our results suggest that BAL is at least
complementary to HRCT in the non-invasive diagnostic
evaluation of IIP. Therefore, BAL as well as chest HRCT
should be performed as a routine procedure in IIP.
Previous studies suggested that patients with BAL
neutrophilia showed a poor prognosis in UIP/NSIP.16,17,20,21
BAL neutrophilia, however, had no prognostic value in our
study. It might be because the follow-up duration of our
patients was relatively short. Regardless of the presence of
BAL neutrophilia, our data suggests that BAL lymphocytosis
can be an independent prognostic factor in IIP. UIP is an
ultimately fatal disease unresponsive to corticosteroids
and/or cytotoxic agents, but NSIP usually shows a favorable
treatment response.7–12 When surgical lung biopsy is not
feasible in patients with fibrotic IIP, BAL lymphocytosis can
be an objective parameter predictive of a good treatment
response.16,18–20
Our result is contrasted with the report by Veeraraghavan
et al.23 which concluded that the BAL findings in 54 patients
with a clinical diagnosis of UIP had no diagnostic role in
discriminating between UIP and NSIP. The most plausible
explanation for this discrepancy is the difference in the
number of patients. The number of our patients is 122, much
more than that of Veeraraghavan’s study. Since the
histopathologic distinction between UIP and fibrotic NSIP is
very difficult in some cases,4,5 increasing the number of
patients could decrease the error in the histologic diagnosis.
As we had already excluded 26 patients whose histopatho-
logic diagnosis was uncertain, the possibility of histopatho-
logic misclassification in 122 patients would be very low. The
typical pattern of the differential cell count in BAL fluid has
also been reported in individual entity of IIP in other
studies.8,9,20,22,27
Our study has several drawbacks. It is a retrospective
study in nature; hence, our observations remain to be
confirmed in a prospective study. Second, our patients might
have less severe disease since all of them tolerated surgical
lung biopsy under general anesthesia. The longer median
survival of our patients compared to the previous re-
ports10,12,19 may well reflect this. Thirdly, since our follow-
up duration is relatively short, the role of BAL in predicting
prognosis needs to be verified in a long-term follow-up
study. Lastly, BAL findings had no prognostic value once the
histologic distinction between UIP and NSLP had been made.
In conclusion, BAL is useful not only in diagnosing a
variety of specific non-IIP diseases but also in narrowing the
differential diagnosis and predicting the prognosis in fibrotic
IIP. Therefore, BAL should be performed in IIP whenever
possible. A long-term prospective study will be needed to
define the role of BAL more clearly in IIP.
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